Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Nano One Materials Corp

Start price
Target price
Perf. (%)
€2.81
24.10.21
€2.00
24.10.22
-21.89%
28.01.22

Could be worthwhile Investment >10% per year
buy
ReGen III Corp.

Start price
Target price
Perf. (%)
€1.24
20.10.21
-
20.10.22
2.82%
13.03.22

buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€5.98
18.10.21
-
18.10.22
-81.14%
19.10.22

positive Cash Flow expected
Good rating
Normal challenges to pay loans and raise capital
ROE lower than 10% per year
Kinross Gold Corp.

Start price
Target price
Perf. (%)
€5.31
18.10.21
-
18.10.22
-9.74%
13.12.21

Undervalued
Very high dividend yield expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Eldorado Gold Corp.

Start price
Target price
Perf. (%)
€8.33
18.10.21
-
18.10.22
-6.91%
13.12.21

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
IAMGOLD Corp.

Start price
Target price
Perf. (%)
€2.34
18.10.21
-
18.10.22
-11.81%
28.05.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
buy
Just Energy Group

Start price
Target price
Perf. (%)
€1.34
18.10.21
€1.00
18.10.22
-84.59%
18.05.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
High valuation
buy
BriaCell Therapeutics Corp.

Start price
Target price
Perf. (%)
€6.95
18.10.21
€11.00
31.12.23
-5.76%
08.05.23

Could be very worthwhile Investment >20% year
buy
Rock Tech Lithium Inc.

Start price
Target price
Perf. (%)
€6.50
17.10.21
-
17.10.22
-69.00%
18.10.22

Could be very worthwhile Investment >20% year
buy
ReGen III Corp.

Start price
Target price
Perf. (%)
€1.16
13.10.21
€15.00
13.10.24
-13.94%
14.06.22

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.87
13.10.21
€10.00
13.10.24
-4.83%
15.06.22

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
Tsodilo Resources Ltd

Start price
Target price
Perf. (%)
€0.56
13.10.21
€5.70
13.10.24
-87.46%
02.08.24

Rising EBIT margin expected
Good culture
Innovative
Could be very worthwhile Investment >20% year
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€8.50
13.10.22
-1.14%
13.10.21

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.00
05.10.21
-
05.10.22
-10.00%
08.12.21

Probably not worthwhile Investment
buy
Aya Gold & Silver Inc.

Start price
Target price
Perf. (%)
€5.35
04.10.21
-
04.10.22
20.56%
15.10.21

Could be very worthwhile Investment >20% year
buy
IAMGOLD Corp.

Start price
Target price
Perf. (%)
€1.99
04.10.21
-
04.10.22
10.22%
12.10.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
buy
Jaguar Mining Inc.

Start price
Target price
Perf. (%)
€2.65
02.10.21
€2.10
28.12.23
17.74%
28.12.21

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.92
28.09.21
-
28.09.22
-6.85%
02.10.21

Could be worthwhile Investment >10% per year
buy
Ceapro Inc

Start price
Target price
Perf. (%)
€0.41
27.09.21
€0.88
27.09.24
-
27.02.24

buy
DAVIDsTEA Inc

Start price
Target price
Perf. (%)
€2.30
27.09.21
€3.80
27.09.22
6.96%
02.03.22

buy
Eldorado Gold Corp.

Start price
Target price
Perf. (%)
€7.00
23.09.21
-
23.09.22
6.29%
12.10.21

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year